The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis | PTCE Pharmacy Connect

Pharmacy Times Continuing Education (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-systems pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multi-specialty education. The Managed Care Implications of Cost, Disease Burden, and Quality of Life in Myelofibrosis Educational Objective: Recognize the quality-of-life impacts and cost of therapy challenges patients with myelofibrosis face and explore strategies available to better manage this diagnosis. Melissa Pozotrigo, PharmD, BCOP Senior Clinical Pharmacist OncoHealth Atlanta, Georgia Melissa Pozotrigo, PharmD, BCOP, has no financial relationships with commercial interests to disclose. Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-397-H01-P. The activity is available for CE credit through August 29, 2023. This activity is supported by an educational grant from Incyte Corporation. Learn more about your ad choices. Visit megaphone.fm/adchoices